Ranexa - 61958-1004-2 - (ranolazine)

Alphabetical Index


Drug Information of Ranexa

Product NDC: 61958-1004
Proprietary Name: Ranexa
Non Proprietary Name: ranolazine
Active Ingredient(s): 1000    mg/1 & nbsp;   ranolazine
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Ranexa

Product NDC: 61958-1004
Labeler Name: Gilead Sciences, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021526
Marketing Category: NDA
Start Marketing Date: 20070212

Package Information of Ranexa

Package NDC: 61958-1004-2
Package Description: 14 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (61958-1004-2)

NDC Information of Ranexa

NDC Code 61958-1004-2
Proprietary Name Ranexa
Package Description 14 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (61958-1004-2)
Product NDC 61958-1004
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name ranolazine
Dosage Form Name TABLET, FILM COATED, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20070212
Marketing Category Name NDA
Labeler Name Gilead Sciences, Inc.
Substance Name RANOLAZINE
Strength Number 1000
Strength Unit mg/1
Pharmaceutical Classes Anti-anginal [EPC]

Complete Information of Ranexa


General Information